Beam Therapeutics (BEAM) Short Interest Ratio & Short Volume → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free BEAM Stock Alerts $24.22 -0.10 (-0.41%) (As of 04:26 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Beam Therapeutics Short Interest DataCurrent Short Interest14,580,000 sharesPrevious Short Interest14,020,000 sharesChange Vs. Previous Month+3.99%Dollar Volume Sold Short$351.52 millionShort Interest Ratio10.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares82,310,000 sharesPercentage of Shares Shorted17.71%Today's Trading Volume755,097 sharesAverage Trading Volume1,374,796 sharesToday's Volume Vs. Average55% Short Selling Beam Therapeutics ? Sign up to receive the latest short interest report for Beam Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBEAM Short Interest Over TimeBEAM Days to Cover Over TimeBEAM Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Beam Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202414,580,000 shares $351.52 million +4.0%N/A10.2 $24.11 4/30/202414,020,000 shares $297.50 million +6.5%N/A9.3 $21.22 4/15/202413,170,000 shares $338.47 million -2.1%N/A8.4 $25.70 3/31/202413,450,000 shares $444.39 million -6.1%N/A9.7 $33.04 3/15/202414,320,000 shares $507.07 million +9.2%N/A10.1 $35.41 2/29/202413,110,000 shares $517.71 million -2.4%N/A9.2 $39.49 Get the Latest News and Ratings for BEAM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202413,430,000 shares $443.46 million +0.3%N/A9.6 $33.02 1/31/202413,390,000 shares $326.72 million +2.0%N/A9.7 $24.40 1/15/202413,130,000 shares $336.13 million -2.7%N/A8.7 $25.60 12/31/202313,490,000 shares $367.20 million +0.1%N/A9.4 $27.22 12/15/202313,480,000 shares $383.10 million +3.7%N/A9.5 $28.42 11/30/202313,000,000 shares $365.04 million -6.0%N/A9.8 $28.08 11/15/202313,830,000 shares $347.82 million -4.3%N/A11.1 $25.15 10/31/202314,450,000 shares $305.47 million -4.3%N/A13.6 $21.14 10/15/202315,100,000 shares $336.13 million +5.2%N/A16.3 $22.26 9/30/202314,350,000 shares $345.12 million +6.2%N/A16.5 $24.05 9/15/202313,510,000 shares $338.43 million +2.9%N/A16.1 $25.05 8/31/202313,130,000 shares $304.35 million +0.5%N/A15.8 $23.18 8/15/202313,060,000 shares $316.97 million +8.8%N/A15.8 $24.27 7/31/202312,000,000 shares $370.44 million -3.7%N/A14.1 $30.87 7/15/202312,460,000 shares $384.52 million -1.4%N/A15.1 $30.86 6/30/202312,630,000 shares $403.28 million +1.5%N/A15.3 $31.93 6/15/202312,450,000 shares $423.30 million -0.5%N/A14.6 $34.00 5/31/202312,510,000 shares $399.07 million -4.9%20.0%13.6 $31.90 5/15/202313,150,000 shares $473.27 million +3.3%21.0%13.4 $35.99 4/30/202312,730,000 shares $390.94 million -1.1%21.4%13.7 $30.71 4/15/202312,870,000 shares $402.44 million -5.4%21.7%13.8 $31.27 3/31/202313,610,000 shares $416.74 million -2.2%22.9%14.6 $30.62 3/15/202313,910,000 shares $488.24 million +11.5%23.5%15.3 $35.10 2/28/202312,480,000 shares $502.20 million +4.4%21.1%14.9 $40.24 2/15/202311,950,000 shares $525.08 million -3.8%20.7%15.2 $43.94 1/31/202312,420,000 shares $539.65 million -4.5%21.5%14.8 $43.45 1/15/202313,010,000 shares $562.55 million +9.0%22.6%15.6 $43.24 12/30/202211,940,000 shares $466.97 million +1.7%20.7%14.3 $39.11 12/15/202211,740,000 shares $496.72 million -5.6%20.4%13.9 $42.31 11/30/202212,440,000 shares $574.60 million -4.4%21.6%14 $46.19 11/15/202213,010,000 shares $639.83 million -0.7%22.6%13.8 $49.18 10/31/202213,100,000 shares $577.19 million +0.2%23.8%12.2 $44.06 10/15/202213,080,000 shares $594.75 million -0.3%23.8%12.2 $45.47 9/30/202213,120,000 shares $625.04 million +5.8%23.9%11.3 $47.64Digitizing the $11T commodities sector with one tiny stock (Ad)One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long 9/15/202212,400,000 shares $750.08 million +2.1%22.6%10 $60.49 8/31/202212,140,000 shares $662.84 million +0.1%22.1%9.3 $54.60 8/15/202212,130,000 shares $852.86 million -6.5%22.1%9.2 $70.31 7/31/202212,970,000 shares $816.85 million -2.0%22.8%9.5 $62.98 7/15/202213,240,000 shares $762.89 million +3.4%23.3%9.5 $57.62 6/30/202212,810,000 shares $495.88 million +10.2%22.6%9.4 $38.71 6/15/202211,620,000 shares $371.26 million +4.6%20.5%8.7 $31.95 5/31/202211,110,000 shares $390.85 million -4.9%19.7%9.1 $35.18 5/15/202211,680,000 shares $414.06 million +8.1%21.7%9.9 $35.45 4/30/202210,810,000 shares $405.70 million +10.5%20.1%10.3 $37.53 4/15/20229,780,000 shares $453.79 million +10.9%18.5%9.3 $46.40 3/31/20228,820,000 shares $505.39 million +3.6%16.9%8.4 $57.30 3/15/20228,510,000 shares $470.09 million -3.6%16.3%9.1 $55.24 2/28/20228,830,000 shares $691.83 million +7.6%17.1%9.8 $78.35 2/15/20228,210,000 shares $606.47 million +4.7%15.9%9.5 $73.87 1/31/20227,840,000 shares $542.61 million +26.5%15.2%9.7 $69.21 1/15/20226,200,000 shares $420.48 million +11.3%11.5%8.8 $67.82 12/31/20215,570,000 shares $443.87 million +1.1%10.4%9.5 $79.69 12/15/20215,510,000 shares $443.72 million +5.6%10.2%9.3 $80.53 11/30/20215,220,000 shares $413.16 million +7.6%9.8%8.6 $79.15 11/15/20214,850,000 shares $419.23 million +3.9%9.1%8.1 $86.44 10/29/20214,670,000 shares $414.56 million -15.4%9.4%7.7 $88.77 10/15/20215,520,000 shares $514.13 million +9.5%11.2%8.7 $93.14 9/30/20215,040,000 shares $438.53 million -3.5%10.2%7.6 $87.01 9/15/20215,220,000 shares $533.01 million -5.6%10.6%6.3 $102.11 8/31/20215,530,000 shares $613.39 million +7.2%11.4%7 $110.92 8/13/20215,160,000 shares $521.26 million +2.8%10.8%6.5 $101.02 7/30/20215,020,000 shares $461.84 million +3.3%11.3%5.8 $92.00 7/15/20214,860,000 shares $415.77 million -9.0%10.9%5.6 $85.55 6/30/20215,340,000 shares $687.31 million -17.5%12.0%5.8 $128.71 6/15/20216,470,000 shares $572.34 million -2.1%15.0%8.1 $88.46 5/28/20216,610,000 shares $517.10 million -4.1%15.3%7.8 $78.23 5/14/20216,890,000 shares $455.70 million +4.7%15.1%6.8 $66.14 4/30/20216,580,000 shares $513.90 million -5.9%14.5%6.3 $78.10 4/15/20216,990,000 shares $534.39 million +3.0%17.6%6.5 $76.45 3/31/20216,790,000 shares $514.41 million +0.3%18.1%6.1 $75.76 3/15/20216,770,000 shares $666.30 million +17.1%18.9%5.9 $98.42 2/26/20215,780,000 shares $511.65 million +8.2%17.7%5 $88.52 2/12/20215,340,000 shares $558.88 million -4.3%16.4%5.2 $104.66 1/29/20215,580,000 shares $557.39 million +0.9%17.1%5.9 $99.89 1/15/20215,530,000 shares $615.60 million No Change16.8%6.1 $111.32 BEAM Short Interest - Frequently Asked Questions What is Beam Therapeutics' current short interest? Short interest is the volume of Beam Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 14,580,000 shares of BEAM short. Learn More on Beam Therapeutics' current short interest. What is a good short interest ratio for Beam Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAM shares currently have a short interest ratio of 10.0. Learn More on Beam Therapeutics's short interest ratio. Which institutional investors are shorting Beam Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Beam Therapeutics: Walleye Trading LLC, Jane Street Group LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Beam Therapeutics' short interest increasing or decreasing? Beam Therapeutics saw a increase in short interest in May. As of May 15th, there was short interest totaling 14,580,000 shares, an increase of 4.0% from the previous total of 14,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Beam Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Beam Therapeutics: Novavax, Inc. (32.26%), Kymera Therapeutics, Inc. (16.09%), ADMA Biologics, Inc. (3.64%), Recursion Pharmaceuticals, Inc. (26.12%), Sana Biotechnology, Inc. (21.23%), Fusion Pharmaceuticals Inc. (3.60%), Inhibrx, Inc. (3.91%), Intellia Therapeutics, Inc. (15.73%), Vericel Co. (9.53%), Ginkgo Bioworks Holdings, Inc. (19.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Beam Therapeutics stock? Short selling BEAM is an investing strategy that aims to generate trading profit from Beam Therapeutics as its price is falling. BEAM shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Beam Therapeutics? A short squeeze for Beam Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAM, which in turn drives the price of the stock up even further. How often is Beam Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAM, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NVAX Short Interest Data KYMR Short Interest Data ADMA Short Interest Data RXRX Short Interest Data SANA Short Interest Data FUSN Short Interest Data INBX Short Interest Data NTLA Short Interest Data VCEL Short Interest Data DNA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BEAM) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlacePresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.